Psychiatr. praxi. 2021;22(1):35-40 | DOI: 10.36290/psy.2021.005

News in brain stimulation methods

doc. MUDr. Bc. Libor Ustohal, Ph.D.1, 2
1 Psychiatrická klinika LF MU a FN Brno
2 Ústav farmakologie a toxikologie, Farmaceutická fakulta Masarykovy univerzity, Brno

Brain neurostimulation methods make a rapidly developing field of psychiatry. They can be divided into invasive and non-invasive methods. The latter group has been used in psychiatry more frequently. This group consists of transcranial magnetic stimulation, transcranial direct current stimulation and also electroconvulsive therapy. While electroconvulsive therapy and transcranial magnetic stimulation are used in clinical practice, transcranial direct current stimulation is still an experimental method. The article presents and discusses selected news published in scientific literature about these methods.

Keywords: neurostimulation methods, electroconvulsive therapy, transcranial magnetic stimulation, transcranial direct current stimulation.

Published: April 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ustohal L. News in brain stimulation methods. Psychiatr. praxi. 2021;22(1):35-40. doi: 10.36290/psy.2021.005.
Download citation

References

  1. Gazdag G, Dragasek J, Takács R, Lookene M, Sobow T, Olekseev A, Ungvari GS. Use of electroconvulsive therapy in Central‑eastern European countries: An overview. Psychiatria Danubina 2017; 29(2): 136-140. Go to original source... Go to PubMed...
  2. Hořínková J, Bartečků E, Kališová L. The practice of electroconvulsive therapy in children and adolescents in the Czech republic. Journal of ECT: in press.
  3. Bahji A, Hawken ER, Sepehry AA, Cabrera CA, Vazquez G. ECT beyond unipolar major depression: systematic review and meta‑analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatrica Scandinavica 2019; 139: 214-226. Go to original source... Go to PubMed...
  4. Lloyd JR, Silverman ER, Kugler JL, Cooper JJ. Electroconvulsive therapy for patients with catatonia: Current perspectives. Neuropsychiatric Disease and Treatment 2020; 16: 2191-2208. Go to original source... Go to PubMed...
  5. Kuhlwilm L, Schönfeldt‑Lecuona C, Gahr M, Connemann BJ, Keller F, Sartorius A. The neuroleptic malignant syndrome - a systematic case series analysis focusing on therapy regimes and outcome. Acta Psychiatrica Scandinavica 2020; 142: 233-241. Go to original source... Go to PubMed...
  6. Petrides G, Malur C, Braga RJ, Bailine SH, Schooler NR, Malhotra AK, et al. Electroconvulsive therapy augmentation in clozapine‑resistant schizophrenia: a prospective, randomized study. American Journal of Psychiatry 2015; 172(1): 52-58. Go to original source... Go to PubMed...
  7. Lally J, Tully J, Robertson D, et al. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta‑analysis. Schizophrenia Research 2016; 171: 215-224. Go to original source... Go to PubMed...
  8. Sinclair DJM, Zhao S, Qi F, Nyakyoma K, Kwong JSW, Adams C. Electroconvulsive therapy for treatment‑resistant schizophrenia. Cochrane Database of Systematic Reviews 2019; 3: CD011847. Go to original source... Go to PubMed...
  9. Landry M, Lafreniere S, Patry S, Potvin S. The clinical relevance of dose titration in electroconvulsive therapy: A systematic review of literature. Psychiatry Research 2020; 294: 113497. Go to original source... Go to PubMed...
  10. Niu Y, Ye D, You Y, Wu J. Prophylactic cognitive enhancers for improvement of cognitive function in patients undergoing electroconvulsive therapy: A systematic review and meta‑analysis. Medicine 2020; 99: 11(e19527). Go to original source... Go to PubMed...
  11. Lefaucheur J‑P, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazarro V, et al. Evidence‑based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clinical Neurophysiology 2020; 131: 474-528. Go to original source... Go to PubMed...
  12. Wobrock T, Guse B, Cordes J, Wölver W, Winterer G, Gaebel W, et al. Left prefrontal high‑frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham controlled, randomized multicenter study. Biological Psychiatry 2015; 77: 979-988. Go to original source... Go to PubMed...
  13. Wölver W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, et al. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimulation 2014; 7: 559-563. Go to original source... Go to PubMed...
  14. Zhao S, Kong J, Li S, Tong Z, Yang C, Zhong H. Randomized controlled trial of four protocols of repetitive transcranial magnetic stimulation for treating the negative symptoms of schizophrenia. Shanghai Archives of Psychiatry 2014; 26: 15-21. Go to PubMed...
  15. Li Z, Yin M, Lyu XL, Zhang LL, Du XD, Hung GC. Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: Findings from a randomized controlled trial. Psychiatry Research 2016; 240: 333-35. Go to original source... Go to PubMed...
  16. Sonmez AI, Camsari DD, Nandakumar AL, Vande Voort JL, Kung S, Lewis CP, Croarkin PE. Accelerated TMS for depression: A systematic review and meta‑analysis. Psychiatry Research 2019; 273: 770-781. Go to original source... Go to PubMed...
  17. Chen L, Hudaib A‑R, Hoy KE, Fitzgerald PB. Efficacy, efficiency and safety of high‑frequency repetitive transcranial magnetic stimulation applied more than once a day in depression: A systematic review. Journal of Affective Disorders 2020; 227: 986-996. Go to original source... Go to PubMed...
  18. Chu H‑T, Cheng C‑M, Liang C‑S, Chang W‑H, Juan C‑H, Huang Y‑Z, et al. Efficacy and tolerability of theta‑burst stimulation for major depression: A systematic review and meta‑analysis. Progress in Neuropsychopharmacology and Biological Psychiatry 2021; 106: 110168. Go to original source... Go to PubMed...
  19. Nguyen TD, Hieronymus F, Lorentzen R, McGirr A, Ostergaard S. The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: A systematic review and meta‑analysis. Journal of Affective Disorders 2021; 279: 250-255. Go to original source... Go to PubMed...
  20. Overvliet GM, Jansen RAC, van Balkom AJLM, van Campen DC, Oudega ML, van der Werf YD, et al. Adverse events of repetitive transcranial magnetic stimulation in older adults with depression, a systematic review of literature. International Journal of Geriatric Psychiatry 2020; 1-10. Go to original source... Go to PubMed...
  21. Holczer A, Németh VL, Vékony T, Vécsei L, Klivényi P, Must A. Non‑invasive brain stimulation in Alzheimer's disease and mild cognitive impairment - A state‑of‑the‑art review on methodological characteristics and stimulation parameters. Frontiers in Human Neuroscience 2020; 14: 179. Go to original source... Go to PubMed...
  22. Kan RLD, Zhang BBB, Zhang JJQ, Kranz GS. Non‑invasive brain stimulation for posttraumatic stress disorder: a systematic review and meta‑analysis. Translational Psychiatry 2020; 10: 168. Go to original source... Go to PubMed...
  23. Hansbauer M, Wagner E, Strube W, Roth A, Padberg F, Keeser D, et al. rTMS and tDCS for the treatment of catatonia: A systematic review. Schizophrenia Research 2020; 222: 73-78. Go to original source... Go to PubMed...
  24. Serafini G, Canepa G, Aguglia A, Amerio A, Bianchi D, Magnani L, et al. Effects of repetitive transcranial magnetic stimulation on suicidal behavior: A systematic review. Progress in Neuropsychopharmacology and Biological Psychiatry 2021; 105: 109981. Go to original source... Go to PubMed...
  25. Duriez P, Khalil RB, Hamoun Y, Maatoug R, Strumila R, Seneque M, et al. Brain stimulation in eating disorders: State of the art and future perspectives. Journal of Clinical Medicine 2020; 9: 2358. Go to original source... Go to PubMed...
  26. Westwood SJ, Radua J, Rubia K. Noninvasive brain stimulation in children and adults with attention deficit/hyperactivity disorder: a systematic review and meta‑analysis. Journal of Psychiatry and Neuroscience: in press.
  27. Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, et al. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clinical Neurophysiology 2017; 128(9): 1774-1809. Go to original source... Go to PubMed...
  28. Razza LB, Palumbo P, Moffa AH, Carvalho AF, Solmi M, Loo CK, Russovsky Brunoni A. A systematic review and meta‑analysis on the effects of transcranial direct current stimulation in depressive episodes. Depress Anxiety 2020; 37: 594-608. Go to original source... Go to PubMed...
  29. Rashidi S, Jones M, Murillo‑Rodriguez E, Machado S, Hao Y, Yadollahpour A. Transcranial direct current stimulation for auditory verbal hallucinations: a systematic review of clinical trials. Neural Regen Res 2021; 16(4): 666-671. Go to original source... Go to PubMed...
  30. Narita Z, Stickley A, DeVylder J, Yokoi Y, Inagawa T, Yamada Y, et al. Effect of multi‑session prefrontal transcranial direct current stimulation on cognition in schizophrenia: A systematic review and meta‑analysis. Schizophrenia Research 2020; 216: 367-373. Go to original source... Go to PubMed...
  31. Yu L, Fang X, Chen Y, Wang Y, Wang D, Zhang C. Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta‑analysis. Schizophrenia Research 2020; 224: 2-10. Go to original source... Go to PubMed...
  32. Kim HJ, Kang N. Bilateral transcranial direct current stimulation attenuated symptoms of alcohol use disorder: A systematic review and meta‑analysis. Progress in Neuropsychopharmacology and Biological Psychiatry 2020: in press. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.